|
| Press Releases |
|
 |
|
| Tuesday, March 14, 2023 |
|
|
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results, New Business Strategy Focused on Precision Oncology |
Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial results for the fourth quarter and full year ended December 31, 2022.
more info >> |
|
| Saturday, March 4, 2023 |
|
|
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology |
| Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board (the 'SAB') to provide strategic input based on their scientific knowledge and clinical expertise to help guide the further development of Prenetics' diagnostic cancer genomics platform. more info >> |
|
| Thursday, January 26, 2023 |
|
|
Cantor Fitzgerald Initiates Coverage on Prenetics with "Overweight" Rating |
| It is reported that Cantor Fitzgerald initiated coverage on Prenetics Global (PRE.US) with "Overweight" rating and target price at USD7.00. more info >> |
|
| Wednesday, January 11, 2023 |
|
|
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors |
| Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced that ACT Genomics, a company which Prenetics recently acquired a majority stake in, has received clearance from the U.S. Food and Drug Administration (FDA) for ACTOnco more info >> |
|
| Friday, December 16, 2022 |
|
|
Prenetics Acquires ACT Genomics; First M&A Deal since IPO, Set to Expand Footprint in Cancer Genomics |
| Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, is acquiring a majority stake of ACT, an Asia based genomics company specializing in precision oncology with operations in Hong Kong, Taiwan, Japan, Singapore, Thailand and the UK, for an upfront consideration consisting of 19.9 million shares of Prenetics common stock and US $20 million cash (the "transaction"). more info >> |
|
| Wednesday, November 30, 2022 |
|
|
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index |
| Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced that its board of directors has authorized a share repurchase program, and that it has been included as a constituent stock in the MSCI Global Micro Cap Index (Hong Kong), with such inclusion to become effective after the U.S. market close today. more info >> |
|
| Thursday, November 10, 2022 |
|
|
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance |
| Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the third quarter ended September 30, 2022. more info >> |
|
| Friday, September 9, 2022 |
|
|
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook |
| Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a global leader in genomic and diagnostic testing, today announced its unaudited financial results for the second quarter ended June 30, 2022. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
EuroEyes Delivers Solid Results in 2022
Mar 28, 2023 23:15 HKT/SGT
|
|
|
Everbright Grand China Announces 2022 Annual Results
Mar 28, 2023 21:03 HKT/SGT
|
|
|
New Digital Badge Program Elevates Cority Software Users as Platform Experts
Mar 28, 2023 20:00 HKT/SGT
|
|
|
Q'Apel Medical Inc. Granted CE Mark Under MDR for Their Walrus Balloon Guide Catheter
Mar 28, 2023 20:00 HKT/SGT
|
|
|
Inaugural InnoEX promoting Hong Kong's Innovation and Technology Development 
Mar 28, 2023 19:00 HKT/SGT
|
|
|
Envision Pharma Group Appoints Richard Gorman as President, Strategic Consulting
Mar 28, 2023 19:00 HKT/SGT
|
|
|
U.S. Polo Assn. Outfits USA Team in Prestigious Westchester Cup, Airing on ESPN
Mar 28, 2023 19:00 HKT/SGT
|
|
|
CITIC Telecom CPC Launches its 3rd Security Operations Center
Mar 28, 2023 18:43 HKT/SGT
|
|
|
Samaiden Gets Bursa Approval for the transfer to Main Market
Mar 28, 2023 17:40 HKT/SGT
|
|
|
OrbusNeich Plans to Set up Its Largest R&D and Production Base in Fuchun Bay New Town, Hangzhou, the PRC
Mar 28, 2023 17:28 HKT/SGT
|
|
|
PT Resources Posts 32% Gain in 3Q Revenue to RM115.4 Million
Mar 28, 2023 17:00 HKT/SGT
|
|
|
Rapid Progress on Installation of INNIO's Hydrogen Production
Mar 28, 2023 16:00 HKT/SGT
|
|
|
Tech Week Singapore Presents: Must-Attend Summits For Asia's Top Business Leaders and Press
Mar 28, 2023 14:05 HKT/SGT
|
|
|
Mitsubishi Shipbuilding Holds Launch Ceremony in Shimonoseki for Demonstration Test Ship for Liquefied CO2 Transport
Mar 28, 2023 14:07 JST
|
|
|
SCIB Granted RM16.8 Million Contract for School Construction
Mar 28, 2023 13:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
